If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDalata Hotel Gp Regulatory News (DAL)

Share Price Information for Dalata Hotel Gp (DAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 358.00
Bid: 332.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 54.00 (16.265%)
Open: 358.00
High: 0.00
Low: 0.00
Prev. Close: 358.00
DAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dalata Hotel Group PLC: Trading Update

13 Dec 2023 07:00

Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: Trading Update 13-Dec-2023 / 07:00 GMT/BST


Trading Update - Another Record Year of Growth

Acquisitions in London, Edinburgh and Amsterdam during 2023

Pipeline of 834 rooms due to open across the UK in 2024 including fifth hotel in London

ISE: DHG              LSE: DAL

 

Dublin and London | 13 December 2023:  Dalata Hotel Group Plc (“Dalata” or “the Group”), the largest hotel operator in Ireland, with a growing presence in the United Kingdom and continental Europe, provides a trading update for the second half of 2023.

The Group continues to deliver an exceptional performance through strong trading and sustained growth. Hotel revenuei for the year 2023 is expected to exceed €600 million (2022: €516 million) and Adjusted EBITDA[i] for the year is expected to be in excess of €220 million (2022: €183 million). For the second half of 2023, Group RevPAR[ii] is expected to be 3% ahead of 2022 levels.

Operations have successfully commenced at the three hotels added to the portfolio during 2023 namely Maldron Hotel Finsbury Park, Clayton Hotel London Wall and Clayton Hotel Amsterdam American. The Group is pleased with the performance delivered to date at each of these hotels.

The Group looks forward to the completion of four new hotels during 2024, with its first hotel in both Brighton and Liverpool, its fourth hotel in Manchester and its fifth hotel in London. This will add 834 rooms to the portfolio. Development works are progressing well and the hotels are on track to open in mid-2024.

The Group is optimistic in its outlook for 2024 with strong lead indicators across our customer segments, including the return of more direct flight connections and the anticipated further recovery in corporate travel.

 

Dermot Crowley, CEO, Dalata said:

“Dalata is on course to deliver another exceptional result this year driven by strong operational performance across our existing hotels and the impact of new additions to the portfolio. This is a testament to the hard work, professionalism and dedication of all our people across our hotels and central office.

In our recent first-half results, we set out our firepower potential of €750 million to grow in the medium term beyond our currently announced pipeline. Since then, we have secured our second hotel in continental Europe with the addition of the newly rebranded Clayton Hotel Amsterdam American and the acquisition of our first site in Edinburgh where we will develop a four-star Clayton Hotel.

Our growth ambitions, coupled with strong demand across our markets and our financial capacity to secure attractive opportunities underscores our ongoing ability to deliver value to our shareholders.”

-ENDS-

 

 

About Dalata

Dalata Hotel Group plc was founded in August 2007 and listed as a plc in March 2014. Dalata is Ireland’s largest hotel operator, with a growing presence in the UK and continental Europe. The Group’s portfolio comprises 53 three and four-star hotels with 11,412 rooms and a pipeline of over 1,300 rooms. The Group currently has 31 owned hotels, 19 leased hotels and three management contracts. Dalata successfully operates Ireland’s two largest hotel brands, the Clayton and the Maldron Hotels. For the six month period ended 30 June 2023, Dalata reported revenue of €284.8 million and a profit after tax of €42.0 million. Dalata is listed on the Main Market of Euronext Dublin (DHG) and the London Stock Exchange (DAL). For further information visit: www.dalatahotelgroup.com

Contacts

Dalata Hotel Group plc

Tel +353 1 206 9400

Dermot Crowley, CEO

investorrelations@dalatahotelgroup.com

Carol Phelan, CFO

 Niamh Carr, Head of Investor Relations and Strategic Forecasting

 

Joint Company Brokers

 

Davy: Anthony Farrell

Tel +353 1 679 6363

Berenberg: Ben Wright

Tel +44 20 3753 3069

 

 

Investor Relations and PR | FTI Consulting

Tel +353 86 401 5250

Melanie Farrell

dalata@fticonsulting.com

 

 


[i] Refer to the Supplementary Financial Information within the Group’s results announcement for the six months ended 30 June 2023 for definitions

[ii] RevPAR is stated on a ‘like for like’ basis and excludes the performance of hotels that newly opened or ceased trading under the Group during the comparative years. For newly acquired, previously operating hotels, where pre-acquisition RevPAR data is available, these hotels are included on a ‘like for like’ basis.


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:IE00BJMZDW83, IE00BJMZDW83
Category Code:TST
TIDM:DAL,DHG
LEI Code:635400L2CWET7ONOBJ04
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:291536
EQS News ID:1795499
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
2nd Jan 201912:16 pmRNSTotal Voting Rights
20th Dec 201812:00 pmRNSHolding(s) in Company
18th Dec 20187:00 amRNSTrading Update
12th Dec 20183:33 pmRNSHolding(s) in Company
3rd Dec 20188:57 amRNSTotal Voting Rights
30th Nov 20184:53 pmRNSDirector/PDMR Shareholding
30th Nov 20182:22 pmRNSHolding(s) in Company
23rd Nov 20182:12 pmRNSDirector/PDMR Shareholding
23rd Nov 20182:11 pmRNSDirector/PDMR Shareholding
23rd Nov 20182:10 pmRNSDirector/PDMR Shareholding
23rd Nov 201812:27 pmRNSHolding(s) in Company
16th Nov 20184:51 pmRNSAcquisition
12th Nov 201811:57 amRNSHolding(s) in Company
8th Nov 20187:00 amRNSStatement re Block Listing Application
5th Nov 20184:15 pmRNSStatement re Refinancing
30th Oct 20188:58 amRNSHolding(s) in Company
1st Oct 20183:00 pmRNSTotal Voting Rights
28th Sep 20184:35 pmRNSHolding(s) in Company
20th Sep 201810:10 amRNSDirector/PDMR Shareholding
17th Sep 201810:02 amRNSConversion Rate for 2018 Interim Dividend
7th Sep 20189:22 amRNSDirector/PDMR Shareholding
7th Sep 20187:00 amRNSDirector/PDMR Shareholding
4th Sep 20187:00 amRNSHalf-year Report
3rd Sep 20182:41 pmRNSTotal Voting Rights
30th Aug 201812:50 pmRNSHolding(s) in Company
29th Aug 20187:00 amRNSAcquisition of London Hotel
1st Aug 20189:13 amRNSTotal Voting Rights
25th Jul 201812:09 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSNotice of Results
23rd Jul 20182:39 pmRNSHolding(s) in Company
2nd Jul 201810:20 amRNSTotal Voting Rights
6th Jun 20183:55 pmRNSTotal Voting Rights
6th Jun 20187:00 amRNSMain Securities Market Notice
5th Jun 20187:00 amRNSBlocklisting Application
16th May 20187:00 amRNSAnnounces Two New Hotels in Bristol & Birmingham
3rd May 20184:18 pmRNSResult of AGM
3rd May 20187:00 amRNSAGM Statement
1st May 20188:27 amRNSTotal Voting Rights
11th Apr 20183:20 pmRNSDirector/PDMR Shareholding
10th Apr 20188:12 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSMain Securities Market Notice
9th Apr 20182:00 pmRNSBlock Listing Application
3rd Apr 20184:35 pmRNSPrice Monitoring Extension
3rd Apr 20189:14 amRNSTotal Voting Rights
29th Mar 20185:00 pmRNSAnnual Financial Report
21st Mar 20183:59 pmRNSDirector/PDMR Shareholding
20th Mar 20183:55 pmRNSHolding(s) in Company
12th Mar 20183:51 pmRNSDirector/PDMR Shareholding
1st Mar 20181:34 pmRNSTotal Voting Rights
27th Feb 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.